Innovation
9 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 469 times.
| Year | Filings |
|---|---|
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 3 |
Investor mix
7 investors on record; lead investors include Advent Life Sciences, Gurnet Point Capital, Roche, Roche.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 1 | 14% |
| Other / undisclosed | 2 | 29% |